In this work, we contribute a multi-institutional series of three further cases of IHG harboring this particular RTK gene fusion, aiming to comparatively illustrate the clinico-pathological characteristics of TRIM24::MET fusion-driven IHG and expand the spectrum of renowned recurrent MET gene fusions in pediatric gliomas. This evidence concerns the gene MET and central nervous system cancer.